Patents by Inventor Jonathan Grote

Jonathan Grote has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170336416
    Abstract: Disclosed herein is a composition for enhancing chemiluminescence and a method of using the composition to improve analyte detection.
    Type: Application
    Filed: June 19, 2017
    Publication date: November 23, 2017
    Inventor: Jonathan Grote
  • Publication number: 20150330986
    Abstract: Disclosed herein is a composition for enhancing chemiluminescence and a method of using the composition to improve analyte detection.
    Type: Application
    Filed: May 15, 2014
    Publication date: November 19, 2015
    Inventor: Jonathan Grote
  • Patent number: 8993248
    Abstract: Vitamin D binding proteins (DBP), in particular truncated DBP and mutated, truncated DBP, as well as fusion proteins thereof, nucleic acid molecules encoding same, vectors, host cells, and methods, kits and solid supports for determining the total amount of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in a test sample.
    Type: Grant
    Filed: December 23, 2012
    Date of Patent: March 31, 2015
    Assignee: Abbott Laboratories
    Inventors: Christian Beckert, Susan E. Brophy, Jonathan Grote, Dagang Huang, Jan Schultess, Bailin Tu
  • Publication number: 20130295593
    Abstract: Vitamin D binding proteins (DBP), in particular truncated DBP and mutated, truncated DBP, as well as fusion proteins thereof, nucleic acid molecules encoding same, vectors, host cells, and methods, kits and solid supports for determining the total amount of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in a test sample.
    Type: Application
    Filed: December 23, 2012
    Publication date: November 7, 2013
    Inventors: Christian Beckert, Susan E. Brophy, Jonathan Grote, Dagang Huang, Jan Schultess, Bailin Tu
  • Publication number: 20110294994
    Abstract: The invention provides more effective methods of separating the components of gentamicin using a UV active protecting group suitable for use with HPLC.
    Type: Application
    Filed: May 12, 2011
    Publication date: December 1, 2011
    Applicant: ABBOTT LABORATORIES
    Inventor: Jonathan Grote
  • Patent number: 6472227
    Abstract: The present invention is directed to a fluorescence polarization immunoassay for barbiturates, to the various components needed for preparing and carrying out such an assay, and to methods of making these components. Specifically, tracers, immunogens and antibodies are disclosed, as well as methods for preparing them and a reagent kit containing them. The tracers and the immunogens are made from substituted barbiturate compounds. A fluorescein moiety is included in the tracer, while a poly(amino acid) forms a part of the immunogen. The assay is conducted by measuring the degree of polarization retention of plane—polarized light that has been passed through a sample containing antiserum and tracer.
    Type: Grant
    Filed: March 10, 1993
    Date of Patent: October 29, 2002
    Assignee: Abbott Laboratories
    Inventors: Maciej Adamczyk, Luis A. Cantarero, Robert Edward Dubler, Jonathan Grote, Patrick J. Jonas, Jane Ann Nelson
  • Patent number: 5407834
    Abstract: The present invention is directed to a fluorescence polarization assay for phencyclidine and phencyclidine derivatives, to the various components needed for preparing and carrying out such an assay, and to methods of making these components. Specifically, tracers, immunogens and antibodies are disclosed, as well as methods for making them, and a reagent kit containing them. The tracers and the immunogens are made from substituted phencyclidine compounds. A fluorescein moiety is included in the tracer, while a poly(amino acid) forms a part of the immunogen. The assay is conducted by measuring the degree of polarization retention of plane polarized light that has been passed through a sample containing antiserum and tracer.
    Type: Grant
    Filed: April 27, 1992
    Date of Patent: April 18, 1995
    Assignee: Abbott Laboratories
    Inventors: Robert E. Dubler, Mary P. Frintner, Jonathan Grote, Gregg A. Hadley, David J. Hawksworth, Hal D. Hopkins, Daniel S. Nam, Frank S. Ungemach, Larry K. Wray
  • Patent number: 5356820
    Abstract: Disclosed is a substantially optically pure hapten, useful in an immunoassay for dextropropoxyphene and/or nordextropropoxyphene. The hapten corresponds to a specified structural formula (IX).Also disclosed is an immunogen derived from the hapten as well as an antibody raised in response to an immunogen derived from the hapten.Also disclosed is a fluorescent tracer derived from a substantially optically pure compound corresponding to the hapten, the tracer being useful in an immunoassay for dextropropoxyphene and/or nordextropropoxyphene.Also disclosed is an improved immunoassay for determining dextropropoxyphene and/or nordextropropoxyphene in a biological sample involving a step of contacting the sample with antibodies raised in response to the immunogen.
    Type: Grant
    Filed: May 12, 1993
    Date of Patent: October 18, 1994
    Assignee: Abbott Laboratories
    Inventors: Robert E. Dubler, Jonathan Grote, Donna R. Kuhn
  • Patent number: 5239086
    Abstract: Disclosed is a substantially optically pure hapten, useful in an immunoassay for dextropropoxyphene and/or nordextropropoxyphene. The hapten corresponds to a specified structural formula (IX).Also disclosed is an immunogen derived from the hapten as well as an antibody raised in response to an immunogen derived from the hapten.Also disclosed is a fluorescent tracer derived from a substantially optically pure compound corresponding to the hapten, the tracer being useful in an immunoassay for dextropropoxyphene and/or nordextropropoxyphene.Also disclosed is an improved immunoassay for determining dextropropoxyphene and/or nordextropropoxyphene in a biological sample involving a step of contacting the sample with antibodies raised in response to the immunogen.
    Type: Grant
    Filed: July 29, 1991
    Date of Patent: August 24, 1993
    Assignee: Abbott Laboratories
    Inventors: Robert E. Dubler, Jonathan Grote, Donna R. Kuhn
  • Patent number: 5155212
    Abstract: The present invention is directed to a fluorescence polarization assay for phencyclidine and phencyclidine derivatives, to the various components needed for preparting and carrying out such an assay, and to methods of making these components. Specifically, tracers, immunogens and antibodies are disclosed, as well as methods for making them, and a reagent kit containing them. The tracers and the immunogens are made from substituted phencyclidine compounds. A fluorescein moiety is included in the tracer, while a poly(amino acid) forms a part of the immunogen. The assay is conducted by measuring the degree of polarization retention of plane polarized light that has been passed through a sample containing antiserum and tracer.
    Type: Grant
    Filed: May 29, 1990
    Date of Patent: October 13, 1992
    Assignee: Abbott Laboratories
    Inventors: Robert E. Dubler, Mary P. Frintner, Jonathan Grote, Gregg A. Hadley, David J. Hawksworth, Hal D. Hopkins, Daniel S. Nam, Frank S. Ungemach, Larry K. Wray
  • Patent number: 5099020
    Abstract: The present invention provides methods and compositions for assaying biological samples, such as human serum, for barbiturates. In one aspect, analogs of barbiturates derivatized with fluorescein and analogs of barbiturates derivatized with immunogenic polypeptides are provided. The fluorescent analogs are employed as tracers in a competitive homogeneous immunoassay, i.e., a fluorescence polarization immunoassay, for detecting barbiturates. The immunogenic analogs are employed to make anti-barbiturate antiserum of the invention for use in the immunoassay method. Intermediates for preparing the fluorescent and immunogenic analogs are also provided. Further provided are test kits, comprising a fluorescent tracer and an antiserum according to the invention, for analyzing biological samples by fluorescence polarization immunoassay for the presence of a barbiturate.
    Type: Grant
    Filed: June 27, 1990
    Date of Patent: March 24, 1992
    Assignee: Abbott Laboratories
    Inventors: Jonathan Grote, Hsiang Hu
  • Patent number: 5096838
    Abstract: The present invention provides methods and compositions for assaying biological samples, such as human serum, for barbiturates. In one aspect, analogs of barbiturates derivatized with fluorescein and analogs of barbiturates derivatized with immunogenic polypeptides are provided. The fluorescent analogs are employed as tracers in a competitive homogeneous immunoassay, i.e., a fluorescence polarization immunoassay, for detecting barbiturates. The immunogenic analogs are employed to make anti-barbiturate antiserum of the invention for use in the immunoassay method. Intermediates for preparing the fluorescent and immunogenic analogs are also provided. Further provided are test kits, comprising a fluorescent tracer and an antiserum according to the invention, for analyzing biological samples by fluorescence polarization immunoassay for the presence of a barbiturate.
    Type: Grant
    Filed: November 27, 1989
    Date of Patent: March 17, 1992
    Assignee: Abbott Laboratories
    Inventors: Jonathan Grote, Hsiang Hu